AI HEALTH TECH (01715) announced its interim results for the six months ended June 30, 2025, reporting revenue of RMB 23.94 million, down 57.21% year-on-year; loss attributable to shareholders of RMB 11.5 million, narrowing 50.32% year-on-year; and basic loss per share of RMB 0.08.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.